Marsden Dianne Lesley, Boyle Kerry, Jordan Louise-Anne, Dunne Judith Anne, Shipp Jodi, Minett Fiona, Styles Amanda, Birnie Jaclyn, Ormond Sally, Parrey Kim, Buzio Amanda, Lever Sandra, Paul Michelle, Hill Kelvin, Pollack Michael R P, Wiggers John, Oldmeadow Christopher, Cadilhac Dominique Ann-Michele, Duff Jed
Hunter Stroke Service, Hunter New England Local Health District, Newcastle, Australia.
Faculty of Health and Medicine, University of Newcastle, Newcastle, Australia.
JMIR Res Protoc. 2021 Feb 4;10(2):e22902. doi: 10.2196/22902.
Urinary incontinence (UI) and lower urinary tract symptoms (LUTS) are commonly experienced by adult patients in hospitals (inpatients). Although peak bodies recommend that health services have systems for optimal UI and LUTS care, they are often not delivered. For example, results from the 2017 Australian National Stroke Audit Acute Services indicated that of the one-third of acute stroke inpatients with UI, only 18% received a management plan. In the 2018 Australian National Stroke Audit Rehabilitation Services, half of the 41% of patients with UI received a management plan. There is little reporting of effective inpatient interventions to systematically deliver optimal UI/LUTS care.
This study aims to determine whether our UI/LUTS practice-change package is feasible and effective for delivering optimal UI/LUTS care in an inpatient setting. The package includes our intervention that has been synthesized from the best-available evidence on UI/LUTS care and a theoretically informed implementation strategy targeting identified barriers and enablers. The package is targeted at clinicians working in the participating wards.
This is a pragmatic, real-world, before- and after-implementation study conducted at 12 hospitals (15 wards: 7/15, 47% metropolitan, 8/15, 53% regional) in Australia. Data will be collected at 3 time points: before implementation (T), immediately after the 6-month implementation period (T), and again after a 6-month maintenance period (T). We will undertake medical record audits to determine any change in the proportion of inpatients receiving optimal UI/LUTS care, including assessment, diagnosis, and management plans. Potential economic implications (cost and consequences) for hospitals implementing our intervention will be determined.
This study was approved by the Hunter New England Human Research Ethics Committee (HNEHREC Reference No. 18/10/17/4.02). Preimplementation data collection (T) was completed in March 2020. As of November 2020, 87% (13/15) wards have completed implementation and are undertaking postimplementation data collection (T).
Our practice-change package is designed to reduce the current inpatient UI/LUTS evidence-based practice gap, such as those identified through national stroke audits. This study has been designed to provide clinicians, managers, and policy makers with the evidence needed to assess the potential benefit of further wide-scale implementation of our practice-change package.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/22902.
尿失禁(UI)和下尿路症状(LUTS)在医院成年患者(住院患者)中很常见。尽管相关权威机构建议医疗服务机构建立优化尿失禁和下尿路症状护理的系统,但这些系统往往未得到落实。例如,2017年澳大利亚国家卒中审计急性服务的结果表明,在三分之一患有尿失禁的急性卒中住院患者中,只有18%接受了管理计划。在2018年澳大利亚国家卒中审计康复服务中,41%患有尿失禁的患者中有一半接受了管理计划。很少有报告提及有效住院干预措施以系统地提供优化的尿失禁/下尿路症状护理。
本研究旨在确定我们的尿失禁/下尿路症状实践改变方案在住院环境中提供优化的尿失禁/下尿路症状护理方面是否可行且有效。该方案包括我们从尿失禁/下尿路症状护理的最佳现有证据中综合得出的干预措施,以及针对已识别的障碍和促进因素的理论上合理的实施策略。该方案针对参与病房工作的临床医生。
这是一项在澳大利亚12家医院(15个病房:7/15,47%为大都市医院,8/15,53%为地区医院)进行的务实、真实世界的实施前后研究。将在3个时间点收集数据:实施前(T1)、6个月实施期结束后立即(T2)以及6个月维持期结束后再次(T3)。我们将进行病历审核,以确定接受优化尿失禁/下尿路症状护理(包括评估、诊断和管理计划)的住院患者比例的任何变化。将确定实施我们干预措施对医院的潜在经济影响(成本和后果)。
本研究已获得亨特新英格兰人类研究伦理委员会批准(HNEHREC参考编号18/10/17/4.02)。实施前数据收集(T1)于2020年3月完成。截至2020年11月,87%(13/15)的病房已完成实施并正在进行实施后数据收集(T2)。
我们的实践改变方案旨在缩小当前住院患者尿失禁/下尿路症状基于证据的实践差距,例如通过国家卒中审计所识别的差距。本研究旨在为临床医生、管理人员和政策制定者提供证据,以评估进一步广泛实施我们的实践改变方案的潜在益处。
国际注册报告识别码(IRRID):DERR1-10.2196/22902。